SCHEMBL5577933

SCHEMBL5577933

CNC(=O)Nc1nc2[nH]nc(-n3cncc3-c3ccccc3Cl)c2s1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAK1 Q13153 1/20 0.35
GPBAR1 Q8TDU6 1/20 0.35
SMN1; SMN2 Q16637 4/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
KDM4E B2RXH2 2/20 0.34
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
PKM P14618 1/20 0.34
CASP3 P42574 1/20 0.34
SENP8 Q96LD8 1/20 0.34
HSD17B10 Q99714 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
LIMK1 P53667 2/20 0.34
CA1 P00915 1/20 0.34
CA9 Q16790 1/20 0.34
KMT2A Q03164 4/20 0.32
LMNA P02545 3/20 0.32
MMP3 P08254 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5577957 0.90 LIMK1 (0.44) GPBAR1SMN1; SMN2ALDH1A1HPGDKDM4E
SCHEMBL5577958 0.88 GPBAR1 (0.38) PAK1GPBAR1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL14455002 0.87 LIMK1 (0.47) GPBAR1SMN1; SMN2ALDH1A1HPGDKDM4E
SCHEMBL14455022 0.87 GPBAR1 (0.34) PAK1GPBAR1SMN1; SMN2ALDH1A1HPGD
SCHEMBL14455023 0.87 MEN1 (0.39) PAK1ALDH1A1NPC1KMT2ALMNA
SCHEMBL14454855 0.86 MEN1 (0.45) NPC1CASP3SENP8SENP7SENP6
SCHEMBL14455029 0.86 GPBAR1 (0.34) GPBAR1SMN1; SMN2ALDH1A1HPGDKDM4E
SCHEMBL14455027 0.86 MMP3 (0.48) SMN1; SMN2ALDH1A1KDM4EMMP3MMP1
SCHEMBL14455001 0.86 GSK3B (0.46) SMN1; SMN2ALDH1A1KDM4ENPC1HSD17B10
SCHEMBL14454995 0.86 ALDH1A1 (0.43) GPBAR1SMN1; SMN2ALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators SGX PHARMACEUTICALS, INC. (US) 2007-07-26 US disclosed
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators SGX PHARMACEUTICALS, INC. (US) 2007-07-26 US disclosed
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators SGX PHARMACEUTICALS, INC. (US) 2007-07-26 US disclosed
WO-2007059341-A2 PYRAZOLOTHIAZOLE PROTEIN KINASE MODULATORS SGX PHARMACEUTICALS, INC. (US) 2007-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators MAP4K2, MAP4K5, MAP4K3 PAK1 117/4885GPBAR1 1899/4885SMN1; SMN2 3826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.